RP
RPNRF.US Rapid Nutrition PLC
- Market cap
- USD 4.75M
- P/E
- -
- P/B
- 0.52x
- ROE
- -36.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is RPNRF.US undervalued?
Graham numberThe Graham number of Rapid Nutrition PLC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Rapid Nutrition PLC fundamental analysis
No fundamental analysis for Rapid Nutrition PLC yet.
Rapid Nutrition PLC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Rapid Nutrition PLC
Rapid Nutrition PLC, a natural healthcare company, develops and distributes science-based health and wellness products worldwide. It offers natural and organic ingredients designed to support weight loss under the System LS brand name; herbal medicine for symptoms of sore throat, colds, and flu, as well as added Ashwagandha and Andrographis for strong immunity boost for travelers under the Azurene brand name. It also provides products under the third-party brands. Rapid Nutr…
Full company profileRapid Nutrition PLC financial statements
Rapid Nutrition PLC annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.69M | 3.25M | 4.25M | 3.10M | 2.45M | 3.00M | 2.92M | 1.66M | 917K | 195K |
| Gross Profit | 6.11M | 2.28M | 4.14M | 2.05M | 1.00M | 2.25M | 2.08M | 818K | 482K | 53.2K |
| Operating Income | 946K | 522K | 1.96M | 1.02M | -384K | 439K | -1.18M | -2.16M | -2.90M | -2.64M |
| EBITDA | 954K | 882K | 3.41M | 605K | -241K | 275K | -861K | -1.94M | -1.52M | -2.62M |
| Net Income | 1.95M | 745K | 1.90M | 541K | -3.63M | 238K | -2.36M | -2.14M | -2.90M | -3.12M |
| EPS | 0.08 | 0.03 | 0.06 | 0.02 | -0.09 | 0.01 | 0.00 | 0.00 | 0.00 | -10 |
| Balance Sheet | ||||||||||
| Total Assets | 25.9M | 19.7M | 27.9M | 15.6M | 2.49M | 2.62M | 588K | 918K | 956K | 9.06M |
| Total Liabilities | 8.12M | 6.37M | 5.87M | 4.59M | 3.62M | 3.53M | 480K | 878K | 574K | 549K |
| Shareholders' Equity | 7.39M | 7.91M | 12.3M | 11.6M | -1.13M | -910K | 108K | 40.6K | 381K | 8.52M |
| Cash & Short-term Investments | 5.99M | 5.99M | 11.3M | 6.20M | 990K | 77.5K | 236K | 488K | 95.8K | 8.54M |
| Total Debt | 2.62M | 1.50M | 3.30M | 2.58M | 2.02M | 2.12M | 356K | 195K | 88.1K | 77.8K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -132K | 1.26M | 3.40M | -1.15M | -333K | -146K | -1.30M | -1.55M | -3.00M | -3.15M |
| Capital Expenditure | 4.46 | 9.45K | 4.23K | 7.52 | 3.87K | 0.00 | 0.00 | 0.00 | 3.17 | 1.56K |
| Free Cash Flow | 5.29M | 1.25M | 3.39M | 541K | -337K | -146K | -2.36M | -1.55M | -3.00M | -3.15M |
| Ratios | ||||||||||
| ROE | 26.3% | 9.4% | 15.5% | 4.7% | - | - | -2,184.3% | -5,270.7% | -761.5% | -36.6% |
| ROA | 7.5% | 3.8% | 6.8% | 3.5% | -145.7% | 9.1% | -400.8% | -233.1% | -303.9% | -34.4% |
| Net Profit Margin | 72.4% | 22.9% | 44.8% | 17.4% | -148.1% | 7.9% | -80.7% | -129.3% | -316.7% | -1,596.1% |
| Debt to Equity | 0.35x | 0.19x | 0.27x | 0.22x | - | - | 3.30x | 4.80x | 0.23x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Rapid Nutrition PLC dividends
Rapid Nutrition PLC has not paid dividends in the last 10 fiscal years.
Last stock split: 1:1000 on Jan 23, 2026.
Who owns Rapid Nutrition PLC
Ownership data of Rapid Nutrition PLC is not available yet.
Rapid Nutrition PLC company profile
- Company name
- Rapid Nutrition PLC
- Ticker
- RPNRF.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Pharmaceuticals
- Employees
- 3
- Fiscal year end
- December
- Address
- 82 James Carter Road, Mildenhall, United Kingdom, IP28 7DE
- Phone
- 44 20 8040 3498
- Website
- rnplc.com
About Rapid Nutrition PLC
Rapid Nutrition PLC, a natural healthcare company, develops and distributes science-based health and wellness products worldwide. It offers natural and organic ingredients designed to support weight loss under the System LS brand name; herbal medicine for symptoms of sore throat, colds, and flu, as well as added Ashwagandha and Andrographis for strong immunity boost for travelers under the Azurene brand name. It also provides products under the third-party brands. Rapid Nutrition PLC was founded in 2001 and is based in Mildenhall, the United Kingdom.
Rapid Nutrition PLC management
4- Mr. Simon St. LedgerExecutive Chairman, CEO & MD · born 1973
- Mr. Michael ZhuChief Financial Officer · born 1979
- Dr. John E. Lewis Ph.D.Scientific Director
- Ms. Ruth KendonHead of Research & Product Development